Target Name: RAC1
NCBI ID: G5879
Review Report on RAC1 Target / Biomarker Content of Review Report on RAC1 Target / Biomarker
RAC1
Other Name(s): Rac family small GTPase 1 | Rac1 | Rac-1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | Ras-like protein TC25 | Ras-related C3 botulinum toxin substrate 1 | Migration-inducing gene 5 | RAC1_HUMAN | Cell migration-inducing gene 5 protein | Rac family small GTPase 1, transcript variant Rac1b | Ras-related C3 botulinum toxin substrate 1 (isoform Rac1b) | cell migration-inducing gene 5 protein | Ras-related C3 botulinum toxin substrate 1 (isoform Rac1) | ras-like protein TC25 | RAC1 variant Rac1b | Rac family small GTPase 1, transcript variant Rac1 | Migration-inducing protein 5 | TC-25 | MIG5 | Rho family, small GTP binding protein Rac1b | MRD48 | Rho family, small GTP binding protein Rac1 | p21-Rac1 | RAC1 variant Rac1

RAC1: A Protein Regulator of Cell Signaling and Cellular Processes

The Rac family small GTPase 1 (RAC1) is a protein that plays a crucial role in various cellular processes in the cell. It is a member of the GTPase family 1, which are known for their ability to regulate protein interactions and signaling pathways. RAC1 is a 21-kDa protein that is expressed in most tissues and cells of the body. It is involved in various cellular processes, including cell signaling, cytoskeletal organization, and chromatin remodeling.

One of the key functions of RAC1 is its role in the regulation of protein interactions. It functions as a GTPase, which means it can bind to GTP (guanosine triphosphate) and regulate the assembly and disassembly of other proteins. GTP is a crucial signaling molecule that plays a vital role in various cellular processes, including intracellular signaling, cell division, and survival. RAC1 can regulate the assembly and disassembly of other proteins by interacting with their respective GDPs (Guanosine Diphosphate) or GTPs.

RAC1 is also involved in the regulation of cytoskeletal organization. It is a protein that is involved in the organization of the cytoskeleton, which is the structure that gives cells their shape and supports their mechanical forces. RAC1 is a key regulator of the cytoskeleton by controlling the distribution of microtubules within the cell.

RAC1 is also involved in the regulation of chromatin remodeling. Chromatin remodeling is the process by which the DNA in the nucleus of the cell is organized into specific patterns, which are necessary for gene expression. RAC1 is involved in the regulation of chromatin remodeling by controlling the distribution of histone modifications on the chromatin.

RAC1 is also involved in the regulation of cell signaling. It is a key regulator of the signalling pathway that regulates cell growth, differentiation, and survival. RAC1 can regulate the assembly and disassembly of other proteins involved in this signaling pathway, including the tyrosine kinase pathway.

RAC1 is also a potential drug target. Its involvement in various cellular processes makes it an attractive target for drug development. For example, RAC1 has been shown to be involved in the regulation of cancer cell growth, and inhibition of RAC1 has been shown to be effective in inhibiting the growth of cancer cells. Additionally, RAC1 has also been shown to be involved in the regulation of neurodegenerative diseases, and inhibition of RAC1 has been shown to be effective in treating neurodegenerative diseases.

In conclusion, RAC1 is a protein that plays a crucial role in various cellular processes in the cell. Its involvement in the regulation of protein interactions, cytoskeletal organization, chromatin remodeling, and cell signaling make it an attractive target for drug development. The development of inhibitors of RAC1 for the treatment of various diseases, including cancer and neurodegenerative diseases, is a promising area of research.

Protein Name: Rac Family Small GTPase 1

Functions: Plasma membrane-associated small GTPase which cycles between active GTP-bound and inactive GDP-bound states. In its active state, binds to a variety of effector proteins to regulate cellular responses such as secretory processes, phagocytosis of apoptotic cells, epithelial cell polarization, neurons adhesion, migration and differentiation, and growth-factor induced formation of membrane ruffles (PubMed:1643658, PubMed:28886345). Rac1 p21/rho GDI heterodimer is the active component of the cytosolic factor sigma 1, which is involved in stimulation of the NADPH oxidase activity in macrophages. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. Stimulates PKN2 kinase activity (PubMed:9121475). In concert with RAB7A, plays a role in regulating the formation of RBs (ruffled borders) in osteoclasts (PubMed:1643658). In podocytes, promotes nuclear shuttling of NR3C2; this modulation is required for a proper kidney functioning. Required for atypical chemokine receptor ACKR2-induced LIMK1-PAK1-dependent phosphorylation of cofilin (CFL1) and for up-regulation of ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation. In neurons, is involved in dendritic spine formation and synaptic plasticity (By similarity). In hippocampal neurons, involved in spine morphogenesis and synapse formation, through local activation at synapses by guanine nucleotide exchange factors (GEFs), such as ARHGEF6/ARHGEF7/PIX (PubMed:12695502). In synapses, seems to mediate the regulation of F-actin cluster formation performed by SHANK3. In neurons, plays a crucial role in regulating GABA(A) receptor synaptic stability and hence GABAergic inhibitory synaptic transmission through its role in PAK1 activation and eventually F-actin stabilization (By similarity)

The "RAC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RAC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RAC2 | RAC3 | RACGAP1 | RACGAP1P1 | RACK1 | RAD1 | RAD17 | RAD17-RFC2-5 complex | RAD17P1 | RAD17P2 | RAD18 | RAD21 | RAD21-AS1 | RAD21L1 | RAD23A | RAD23B | RAD50 | RAD51 | RAD51-AS1 | RAD51AP1 | RAD51AP2 | RAD51B | RAD51C | RAD51D | RAD51L3-RFFL | RAD52 | RAD54B | RAD54L | RAD54L2 | RAD9A | RAD9B | RADIL | RADX | RAE1 | RAET1E | RAET1E-AS1 | RAET1G | RAET1K | RAET1L | Raf kinase | RAF1 | RAF1P1 | RAG1 | RAG2 | Ragulator Complex | RAI1 | RAI14 | RAI2 | RALA | RALB | RALBP1 | RALBP1P1 | RalGAP1 complex | RALGAPA1 | RALGAPA2 | RALGAPB | RALGDS | RALGPS1 | RALGPS2 | RALY | RALYL | RAMAC | RAMACL | RAMP1 | RAMP2 | RAMP2-AS1 | RAMP3 | RAN | RANBP1 | RANBP10 | RANBP17 | RANBP1P1 | RANBP2 | RANBP3 | RANBP3-DT | RANBP3L | RANBP6 | RANBP9 | RANGAP1 | RANGRF | RANP1 | RANP6 | RAP1A | RAP1B | RAP1BL | RAP1GAP | RAP1GAP2 | RAP1GDS1 | RAP2A | RAP2B | RAP2C | RAP2C-AS1 | RAPGEF1 | RAPGEF2 | RAPGEF3 | RAPGEF4 | RAPGEF4-AS1 | RAPGEF5 | RAPGEF6 | RAPGEFL1